O benefício da terapia nutrológica parenteral intradialítica
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | International Journal of Nutrology (Online) |
Texto Completo: | https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/128 |
Resumo: | Protein-calorie malnutrition affects 20 to 70% of patients with chronic renal failure (CRF) in hemodialysis treatment (HD), contributing to the high morbidity and mortality rates. The intradialytic parenteral nutrition (IPN) is a therapeutic option for the improvement of nutritional status. Objective: To review the role of intradialytic parenteral nutrition (NPID) as a form of nutritional supplementation for patients with chronic kidney disease on hemodialysis. Conclusion: Malnutrition is common in chronic renal failure patients on hemodialysis and negatively affects prognosis. Most of these patients have low energy and protein in the diet, thus, specific nutritional supplements for kidney disease are needed to meet the energy requirements and protein. The NPID seems to be favorable for long-term improvement of the HD patient’s nutritional status, showing effective in reversing the protein hypercatabolism and increased energy expenditure that occurs during HD. However, it is worth mentioning that NPID presents higher cost to oral nutritional therapy and enteral. Thus, the cost-effectiveness of this access route should be further investigated. |
id |
ABRAN-1_9dfb883f5ffa07bc4e439efcd7b6a1d8 |
---|---|
oai_identifier_str |
oai:ojs2.ijn.zotarellifilhoscientificworks.com:article/128 |
network_acronym_str |
ABRAN-1 |
network_name_str |
International Journal of Nutrology (Online) |
repository_id_str |
|
spelling |
O benefício da terapia nutrológica parenteral intradialíticaintradialytic parenteral nutritionchronic kidney diseaseprotein energy malnutritionProtein-calorie malnutrition affects 20 to 70% of patients with chronic renal failure (CRF) in hemodialysis treatment (HD), contributing to the high morbidity and mortality rates. The intradialytic parenteral nutrition (IPN) is a therapeutic option for the improvement of nutritional status. Objective: To review the role of intradialytic parenteral nutrition (NPID) as a form of nutritional supplementation for patients with chronic kidney disease on hemodialysis. Conclusion: Malnutrition is common in chronic renal failure patients on hemodialysis and negatively affects prognosis. Most of these patients have low energy and protein in the diet, thus, specific nutritional supplements for kidney disease are needed to meet the energy requirements and protein. The NPID seems to be favorable for long-term improvement of the HD patient’s nutritional status, showing effective in reversing the protein hypercatabolism and increased energy expenditure that occurs during HD. However, it is worth mentioning that NPID presents higher cost to oral nutritional therapy and enteral. Thus, the cost-effectiveness of this access route should be further investigated.MetaScience Press2022-02-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/12810.1055/s-0040-1705646International Journal of Nutrology; Vol. 10 No. 4 (2017): International Journal of Nutrology (IJN) - September 2017; 145-1522595-28541984-301110.1055/s-010-45914reponame:International Journal of Nutrology (Online)instname:Associação Brasileira de Nutrologia (ABRAN)instacron:ABRANenghttps://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/128/122Copyright (c) 2022 International Journal of Nutrologyinfo:eu-repo/semantics/openAccessMachado, Renata Silva2022-02-14T13:19:49Zoai:ojs2.ijn.zotarellifilhoscientificworks.com:article/128Revistahttps://ijn.zotarellifilhoscientificworks.com/index.php/ijnONGhttps://ijn.zotarellifilhoscientificworks.com/index.php/ijn/oaiijn@zotarellifilhoscientificworks.com || editorchief@zotarellifilhoscientificworks.com10.544482595-28541984-3011opendoar:2022-02-14T13:19:49International Journal of Nutrology (Online) - Associação Brasileira de Nutrologia (ABRAN)false |
dc.title.none.fl_str_mv |
O benefício da terapia nutrológica parenteral intradialítica |
title |
O benefício da terapia nutrológica parenteral intradialítica |
spellingShingle |
O benefício da terapia nutrológica parenteral intradialítica Machado, Renata Silva intradialytic parenteral nutrition chronic kidney disease protein energy malnutrition |
title_short |
O benefício da terapia nutrológica parenteral intradialítica |
title_full |
O benefício da terapia nutrológica parenteral intradialítica |
title_fullStr |
O benefício da terapia nutrológica parenteral intradialítica |
title_full_unstemmed |
O benefício da terapia nutrológica parenteral intradialítica |
title_sort |
O benefício da terapia nutrológica parenteral intradialítica |
author |
Machado, Renata Silva |
author_facet |
Machado, Renata Silva |
author_role |
author |
dc.contributor.author.fl_str_mv |
Machado, Renata Silva |
dc.subject.por.fl_str_mv |
intradialytic parenteral nutrition chronic kidney disease protein energy malnutrition |
topic |
intradialytic parenteral nutrition chronic kidney disease protein energy malnutrition |
description |
Protein-calorie malnutrition affects 20 to 70% of patients with chronic renal failure (CRF) in hemodialysis treatment (HD), contributing to the high morbidity and mortality rates. The intradialytic parenteral nutrition (IPN) is a therapeutic option for the improvement of nutritional status. Objective: To review the role of intradialytic parenteral nutrition (NPID) as a form of nutritional supplementation for patients with chronic kidney disease on hemodialysis. Conclusion: Malnutrition is common in chronic renal failure patients on hemodialysis and negatively affects prognosis. Most of these patients have low energy and protein in the diet, thus, specific nutritional supplements for kidney disease are needed to meet the energy requirements and protein. The NPID seems to be favorable for long-term improvement of the HD patient’s nutritional status, showing effective in reversing the protein hypercatabolism and increased energy expenditure that occurs during HD. However, it is worth mentioning that NPID presents higher cost to oral nutritional therapy and enteral. Thus, the cost-effectiveness of this access route should be further investigated. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-02-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/128 10.1055/s-0040-1705646 |
url |
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/128 |
identifier_str_mv |
10.1055/s-0040-1705646 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/128/122 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 International Journal of Nutrology info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 International Journal of Nutrology |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MetaScience Press |
publisher.none.fl_str_mv |
MetaScience Press |
dc.source.none.fl_str_mv |
International Journal of Nutrology; Vol. 10 No. 4 (2017): International Journal of Nutrology (IJN) - September 2017; 145-152 2595-2854 1984-3011 10.1055/s-010-45914 reponame:International Journal of Nutrology (Online) instname:Associação Brasileira de Nutrologia (ABRAN) instacron:ABRAN |
instname_str |
Associação Brasileira de Nutrologia (ABRAN) |
instacron_str |
ABRAN |
institution |
ABRAN |
reponame_str |
International Journal of Nutrology (Online) |
collection |
International Journal of Nutrology (Online) |
repository.name.fl_str_mv |
International Journal of Nutrology (Online) - Associação Brasileira de Nutrologia (ABRAN) |
repository.mail.fl_str_mv |
ijn@zotarellifilhoscientificworks.com || editorchief@zotarellifilhoscientificworks.com |
_version_ |
1792204587826937856 |